Supplementary Table 1.
SM | EM | DM | DM-VIP | |
---|---|---|---|---|
WRN-conditioned medium | 50 vol% | 50 vol% | ||
Advanced DMEM/F12 | 50 vol% | 50 vol% | 100 vol% | 100 vol% |
GlutaMax | 1× | 1× | 1× | 1× |
HEPES | 10 mM | 10 mM | 10 mM | 10 mM |
Murine EGF | 50 ng/mL | 50 ng/mL | 50 ng/mL | 50 ng/mL |
N-acetyl cysteine | 1.25 mM | 1.25 mM | 1.25 mM | 1.25 mM |
Primocin | 50 μg/mL | 50 μg/mL | 50 μg/mL | 50 μg/mL |
B27 | 1× | 1× | ||
Gastrin | 10 mM | 10 mM | ||
A83-01 | 500 nM | 500 nM | 500 nM | |
SB202190 | 3 μM | 3 μM | ||
Y-27632 | 10 μMa | 10 μMa | ||
Nicotinamide | 10 mM | |||
PGE2 | 10 nM | |||
VIP | 330 ng/mL |
Advanced DMEM/F-12, Dulbecco's Modified Eagle Medium/Ham's F-12; DM, differentiation medium; EGF, epidermal growth factor; EM, expansion medium; WRN, Wnt-3A, R-spondin 3, Noggin; PGE2, prostaglandin E2; SM, stem medium; VIP, vasoactive intestinal peptide.
Used in the first 48 hours after cell plating to prevent dissociation-induced cell apoptosis.